Results 201 to 210 of about 121,521 (304)

Pharmacological Treatment of Neuropsychiatric Symptoms in Huntington's Disease: A Systematic Review

Movement Disorders Clinical Practice, Volume 12, Issue 4, Page 418-431, April 2025.
ABSTRACT Background Studies focusing on the treatment of neuropsychiatric symptoms (NPS) in Huntington's disease (HD) are scarce and show a wide variation in design, outcome measures and methodological quality. The effectiveness of pharmacological treatment of NPS in HD has not been systematically reviewed so far.
Ruben L. Andriessen, Mayke Oosterloo, Jory Molema, Maud M.J. Daemen, David E.J. Linden, Albert F.G. Leentjens   +5 more
wiley   +1 more source

Disease-Associated Dopamine Receptor D2 Variants Exhibit Functional Consequences Depending on Different Heterotrimeric G-Protein Subunit Combinations. [PDF]

Biomedicines
Niebrügge N, Trovato O, Praschberger R, Lieb A.   +3 more
europepmc   +1 more source

Overexpression of dopamine receptor D2 promotes colorectal cancer progression by activating the β-catenin/ZEB1 axis.

Cancer Sci, 2021
Lee H, Shim S, Kong JS, Kim MJ, Park S, Lee SS, Kim A.   +6 more
europepmc   +1 more source

Dopamine Receptor D2 Gene (DRD2) Polymorphisms, Job Stress, and Their Interaction on Sleep Dysfunction. [PDF]

Int J Environ Res Public Health, 2020
Jiang Y, Liu B, Wu C, Gao X, Lu Y, Lian Y, Liu J.   +6 more
europepmc   +1 more source

Inhibitory control of prolactin and Pit-1 gene promoters by dopamine. Dual signaling pathways required for D2 receptor-regulated expression of the prolactin gene.

, 1991
Harry P. Elsholtz, Andrew M. Lew, Paul R. Albert, V.C. Sundmark   +3 more
openalex   +1 more source

Dynamin and Rab5 regulate GRK2‐dependent internalization of dopamine D2 receptors [PDF]

, 1999
Ken Iwata, Kazumitsu Ito, Atsushi Fukuzaki, Kouichiro Inaki, Tatsuya Haga   +4 more
openalex   +1 more source

In Vitro Signaling Properties of Cannabinoid and Orexin Receptors: How Orexin Receptors Influence Cannabinoid Receptor‐Mediated Signaling

Pharmacology Research &Perspectives, Volume 13, Issue 2, April 2025.
ABSTRACT The co‐expression of different types of G protein‐coupled receptors (GPCRs) in the same cells can have implications for receptor signaling and receptor cross‐talk, potentially altering the apparent potency or efficacy of ligands targeting each receptor.
Kawthar A. Mohamed, Robert B. Laprairie
wiley   +1 more source

Association between dopamine receptor D2 Taq IA gene polymorphism (rs1800497) and personality traits. [PDF]

SAGE Open Med
Olasore HSA, Oyedeji TA, Faleti JO, Ogundele OI, Olashore AA.   +4 more
europepmc   +1 more source

Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. [PDF]

Cancers (Basel), 2020
Hu W, Zhang L, Ferri-Borgogno S, Kwan SY, Lewis KE, Cun HT, Yeung TL, Soliman PT, Tarapore RS, Allen JE, Guan X, Lu KH, Mok SC, Au-Yeung CL.   +13 more
europepmc   +1 more source

Synthesis and In Vitro Evaluation of Novel Dopamine Receptor D₂ 3,4-dihydroquinolin-2(1H)-one Derivatives Related to Aripiprazole. [PDF]

Biomolecules, 2021
Juza R, Stefkova K, Dehaen W, Randakova A, Petrasek T, Vojtechova I, Kobrlova T, Pulkrabkova L, Muckova L, Mecava M, Prchal L, Mezeiova E, Musilek K, Soukup O, Korabecny J.   +14 more
europepmc   +1 more source